News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Sharlene Gill: Practice-changing ALASCCA ph3 trial
Photo from Sharlene Gill/LinkedIn
Jan 29, 2025, 07:39

Sharlene Gill: Practice-changing ALASCCA ph3 trial

Sharlene Gill, Medical Oncologist and Medical Director, Staff Wellness and Engagement at BC Cancer, shared a post on X:

“Practice-changing ALASCCA ph3 trial
ASA 160mg in PIK3CA+ stage II-III CRC
PIK3CA+ in 37%
HR 0.42 for 3yr DFS!”

Sharlene Gill: Practice-changing ALASCCA ph3 trial

ASCOGI25 cancer OncoDaily Oncology Sharlene Gill
Special Coverage
Science
Feb 27, 2025, 11:53
Herbert Loong: Strengthening lung cancer screening in Hong Kong
Blog
Feb 27, 2025, 11:45
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Blog
Feb 27, 2025, 11:44
Homa Dadras: Georgina Long on neoadjuvant immunotherapy for Melanoma patients
Blog
Feb 27, 2025, 11:35
What is geriatric assessment? - CA: A Cancer Journal for Clinicians
Science
Feb 27, 2025, 11:33
Francisco J. Esteva: The practical implications of HER2-Low and HER2-Ultralow breast cancer
Blog
Feb 27, 2025, 11:23
Ramy Sedhom: Mental health is cancer care, and every person deserves support
Blog
Feb 27, 2025, 11:22
A game-changer for Childhood Cancer in India - CancerWorld
Blog
Feb 27, 2025, 11:17
ASCO/AACR Methods in Clinical Cancer Research Workshop
Science
Feb 27, 2025, 11:09
Nitin Jain: Treatment-free remission in Ph+ ALL
Blog
Feb 27, 2025, 11:00
Fadila Kouhen: I had the privilege of co-moderating a urology workshop at the Onco-Urology Congress in Fès
Blog
Feb 27, 2025, 10:58
Abstract submission deadline is approaching for the 7th National Congress of STOR - ESTRO
Drugs
Feb 27, 2025, 10:49
Venclexta (Venetoclax): Uses in Cancer, Side Effects, Dosages, Expectations